UK markets closed

Medifast, Inc. (0K05.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
97.30-0.81 (-0.83%)
At close: 05:53PM GMT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.18
52-week change 3N/A
S&P500 52-week change 3-13.21%
52-week high 398.87
52-week low 397.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 511.96M
Implied shares outstanding 6N/A
Float 89.99M
% held by insiders 11.99%
% held by institutions 188.43%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 36.56
Trailing annual dividend yield 36.69%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin 8.98%
Operating margin (ttm)11.56%

Management effectiveness

Return on assets (ttm)32.33%
Return on equity (ttm)80.31%

Income statement

Revenue (ttm)1.6B
Revenue per share (ttm)142.79
Quarterly revenue growth (yoy)-10.70%
Gross profit (ttm)1.14B
EBITDA 195.79M
Net income avi to common (ttm)143.57M
Diluted EPS (ttm)14.02
Quarterly earnings growth (yoy)-22.10%

Balance sheet

Total cash (mrq)87.69M
Total cash per share (mrq)8.13
Total debt (mrq)26.05M
Total debt/equity (mrq)16.80
Current ratio (mrq)1.58
Book value per share (mrq)14.34

Cash flow statement

Operating cash flow (ttm)194.57M
Levered free cash flow (ttm)154.46M